February 23, 2022
European Colorectal Cancer Awareness Month #ECCAM2022 ‘Colorectal Cancer – Seeking the Answers’
March is European Colorectal Cancer Awareness Month #ECCAM2022
Thank you to all who joined us – speakers and participants – for our launch event on February 23, 2022
You can watch the event videos via the links below:
Colorectal Cancer – Seeking the Answers!
|Impact of Covid-19 on CRC|
|11:35||Zorana Maravic||CEO, Digestive Cancers Europe||Welcome|
|11:40||Vincent de Jong||Patient Advocate|
|When Cancer and Covid Collide - CRC diagnosis during Covid-19|
|11:45||Carlo Senore||Coordinator, Piedmont Region Screening Program||The impact of Covid-19 on CRC screening programmes across Europe|
• How do we overcome hesitancy and population fear of approaching health centres after the impact of the pandemic and new waves?
• What, if any, changes should be made on the CRC programmes performances, workforce and the way they interact with patients in a post covid environment?
• Should invitations to the population extended to include people older than 70 years of age?
|12:00||Mark Lawler||Co-Chair, European Cancer Organisation's Special Network on the Impact of Covid-19 on Cancer|
European Cancer Organisation
|Time to Act - Don’t let Covid-19 stop you from tackling cancer|
|12:05||Luc Colemont||Managing Director|
|Campaigning for CRC awareness|
|CRC Screening – Working on a local level|
• What are the key learnings for successful campaign implementation/working with policy makers?
|Role of national and EU Institutions in tackling CRC|
|12:30||Tit Albreht||Head of the Centre for Health Care at the National Institute of Public Health of Slovenia||Building on the Beating Cancer Plan - Next Steps in Europe|
|12:40||Ciaran Nicholl||Head of the Health in Society Unit in the European Commission’s Joint Research Centre, Directorate for Health, Consumers and Reference Materials||The European Commission Implementation Roadmap and the Future of Screening in Europe: What Needs to Be Done|
• How should the EU encourage Member States to invest in screening programme?
• The reporting of key findings such as level of investment and participation is crucial to monitor the performance of screening programmes, how can the EU institutions encourage MS to focus on reporting and what will the role of research be in understanding obstacles in programmes implementations?
• Early detection has been demonstrated to be cost-saving to the healthcare system. It is essential to ensure the sustainability of the screening efforts that health economic data are captured systematically to evaluate the cost-savings generated by the investment. How can the EU Institutions ensure that total health economic value is measured?
|1:00||Catie Young||DiCE Communication Manager||#ECCAM2022 Awareness Campaign – The answer is: get screened!|
Please contact us for any questions.